Showing results (11-20 of 141) with videos related to
Sort By:
Pageof 15
Haematologica|September 5, 2008
Prospective comparison of subcutaneous versus intravenous administration of bortezomib in patients with multiple myelomaPhilippe Moreau, Valerie Coiteux, Cyrille Hulin, et al.Clinical Lymphoma, Myeloma & Leukemia|July 1, 2023
Predictors of Lenalidomide Refractory Relapse Timing With Newly Diagnosed Multiple Myeloma: A FIRST Trial SubanalysisSalomon Manier, Meletios Dimopoulos, Cyrille Hulin, et al.Leukemia Research|June 6, 2017
Living with the burden of relapse in multiple myeloma from the patient and physician perspectiveCyrille Hulin, Timon Hansen, Louise Heron, et al.Ejhaem|July 18, 2022
Matching-adjusted indirect comparison of efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) as per label compared with modified VTd dosing schedules in patients with newly diagnosed multiple myeloma who are transplant eligiblePieter Sonneveld, María-Victoria Mateos, Adrian Alegre, et al.Lancet (London, England)|January 26, 2002
Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trialBertrand Godeau, Sylvie Chevret, Bruno Varet, et al.Journal of Clinical Medicine|November 7, 2020
Three Drug Combinations in the Treatment of Fit Elderly Multiple Myeloma PatientsHélène Gardeney, Arthur Bobin, Cécile Gruchet, et al.Ejhaem|July 18, 2022
Comparative efficacy and safety of bortezomib, thalidomide, and dexamethasone (VTd) without and with daratumumab (D-VTd) in CASSIOPEIA versus VTd in PETHEMA/GEM in transplant-eligible patients with newly diagnosed multiple myeloma, using propensity score matchingPhilippe Moreau, Cyrille Hulin, Sonja Zweegman, et al.Clinical Lymphoma, Myeloma & Leukemia|July 4, 2026
Real-World Evidence of Immunotherapy Sequencing in Multiple Myeloma: Durable Responses With BCMA-Targeting Bispecific Antibodies Following Prior GPRC5D-Targeting TherapyTitouan Cazaubiel, Cyrille Touzeau, Laure Vincent, et al.Transfusion|June 26, 2003
Hematologic recovery after autologous PBPC transplantation: importance of the number of postthaw CD34+ cellsPierre Feugier, Daniele Bensoussan, Florence Girard, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 29, 2012
Autologous stem cell transplantation: an effective salvage therapy in multiple myelomaEmilie Lemieux, Cyrille Hulin, Denis Caillot, et al.Pageof 15